Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
CJ-033466 is a partial agonist of the serotonin (5-HT) receptor subtype 5-HT4.1 It induces cAMP accumulation in HEK293 cells expressing human 5-HT4D receptors and relaxation of rat tunica muscularis mucosae strips (EC50s = 0.927 and 1.3 nM, respectively). CJ-033466 selectively binds to 5-HT4D over 5-HT1A, 5-HT1B, 5-HT1D, 5-HT2A, and 5-HT2B receptors (Kis = 1.26, >4,820, >5,070, 2,150, 1,400, and 2,900 nM, respectively) and 5-HT3, 5-HT7, and dopamine D2 receptors (Kis = 4,590, >3,890, and 2,150 nM, respectively), as well as a panel of greater than 50 additional receptors at 1,000 nM. CJ-033466 (0.3 mg/kg) increases gastric antral motility in conscious dogs in the fasted or postprandial states. It reverses clonidine-induced decreases in gastric emptying in a dog model of gastroparesis. CJ-033466 also induces superoxide production in a light-dependent manner and is phototoxic to NIH3T3 fibroblasts (IC50s = 11.4 and 203.3 µg/ml in the presence and absence of light, respectively).2
WARNING This product is not for human or veterinary use.
1. 5-
2. In vitro phototoxic potential and photochemical properties of imidazopyridine derivative: A novel 5-